Form 4: Myers Industries VP, Shared Services, Jeffrey Jon Baker, Receives Stock Units

Sentiment:

SEC Form 4 Filing


Jeffrey Jon Baker, VP, Shared Services at Myers Industries, was granted 8,206 restricted stock units on March 7, 2024, according to a Form 4 filing.

Summary

  • Jeffrey Jon Baker, VP, Shared Services at Myers Industries, filed a Form 4 with the SEC.
  • On March 7, 2024, Baker was granted 8,206 restricted stock units.
  • These restricted stock units vest in three equal installments on March 16, 2025, March 16, 2026, and March 16, 2027.
  • Each restricted stock unit represents a contingent right to receive one share of Myers Industries' Common Stock.

Sentiment

Score: 6

Explanation: The document is a routine filing related to executive compensation. It's neither particularly positive nor negative.

Positives

  • The grant of restricted stock units aligns the executive's interests with those of the shareholders.

Future Outlook

The executive will receive shares of common stock as the restricted stock units vest over the next three years.

Industry Context

Granting stock options and restricted stock units is a common practice for publicly traded companies to incentivize and retain key executives.

Comparison to Industry Standards

  • Executive compensation packages, including stock grants, are typically benchmarked against peer companies in the same industry and of similar size.
  • Companies like Berry Global Group, Sonoco Products Company, and Greif, Inc. are potential comparables for executive compensation analysis.

Stakeholder Impact

  • The grant of restricted stock units aligns the executive's interests with those of the shareholders, potentially leading to better company performance.

Key Dates

DateDescription
03/07/2024Reporting person was granted 8,206 restricted stock units
03/16/2025First vesting date for restricted stock units
03/16/2026Second vesting date for restricted stock units
03/16/2027Third vesting date for restricted stock units
03/11/2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.